Pharmesis International Ltd (SGX:BFK) Share Price

Company Profile

Business description
Pharmesis International Ltd is an investment holding company. The company manufactures pharmaceutical products in the form of tablets, granules, pills, and other forms. Its operating segments are Western drugs/TCH Procurement, which are chemically formulated drugs and are marketed under the Kinna brand; TCM-formulated drugs/IP rental, which refer to Traditional Chinese Medicine and are marketed under the Longlife brand; and Distribution, which derives maximum revenue, refers to agency products and internally manufactured products which are marketed through the distribution arm. The company derives revenue from the sale of medicines to domestic customers in China.
Contact
5 Kallang Sector
No. 03-02
Singapore349279
SGP
T: +65 68460766
https://www.pharmesis.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees

Recommended

Investors in cheap ASX share with a narrow moat enjoys a high yield, but there are risks investors should be aware of.

Morningstar | 28 September 2026

Trading at an 18% discount, this wide-moat stock is a rare find.

Malik Ahmed Khan, CFA | 22 September 2026

Discounted exit raises investor concerns.

Yingqi Tan, CFA | 21 September 2026

Index	Last price	Change	% Change
All Ordinaries	8,886.60	35.90	0.41%
CAC 40	8,087.91	9.43	0.12%
DAX 40	25,417.56	43.14	0.17%
Dow JONES (US)	51,481.51	347.11	-0.67%
FTSE 100	10,736.54	51.66	0.48%
HKSE	24,558.15	84.36	-0.34%
NASDAQ	26,820.38	248.34	-0.92%
Nikkei 225	65,481.27	396.35	-0.60%
NZX 50 Index	13,683.63	147.05	-1.06%
S&P 500	7,683.69	59.72	-0.77%
S&P/ASX 200	8,709.30	29.60	0.34%
SSE Composite Index	3,830.45	6.83	0.18%